Farnesoid X receptor blockade attenuates morphological damage, intestinal secretion, and prevents mucus loss induced by SARS-CoV-2 spike protein in the mouse intestine
Journal of Pharmacy and Pharmacology · 03.07.2026 · 78 (7)
DOI: 10.1093/jpp/rgag074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 06.07.2026. Verfasst von André Luis Fernandes Lopes und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Inflammation and Translational Gastroenterology (LIGAT), Post-graduation Program in Biotechnology (PPGBIOTEC), Parnaíba Delta Federal U…. Hauptthemen laut MEDLINE: Receptors, Cytoplasmic and Nuclear, Spike Glycoprotein, Coronavirus, Intestinal Mucosa, COVID-19. Die Arbeit nennt 62 Literaturangaben. Gefördert von: Coordination for the Improvement of Higher Education Personnel, National Council of Technological and Scientific Development.
Abstract (Originalsprache)
Introduction
The SARS-CoV-2 spike protein has been implicated as an important pathogenic factor, including in intestinal disorders. The farnesoid X receptor (FXR), a nuclear receptor highly expressed in the intestine, has been highlighted in several studies investigating its role in different intestinal dysfunctions.
Objectives
This study evaluated whether FXR blockade attenuates spike-induced morphological alterations and intestinal dysfunction.
Methods
Balb/c mice were divided into three groups (PBS, Spike, and DY268-antagonist). A 2–3 cm jejunal loop was surgically prepared, and different substances were inoculated into the loops (200 μl of PBS or 200 μl containing 10 μg of spike protein or 100 μl of DY268 at μmol + 100 μl of spike), followed by 4-h resting period before euthanasia. Chloride (Cl−) was measured, and tissue samples were collected for histomorphometry analysis, mucin and MUC2 evaluation, Paneth cell assessment, malondialdehyde (MDA), and glutathione (GSH) levels. Key findings FXR antagonism attenuated alterations in all histomorphometric parameters, maintained mucin expression and Paneth cells and their granules, and reduced MDA levels, while restoring GSH in the intestinal loop. However, further studies are needed to understand the mechanisms by which FXR blockade modulates spike-induced intestinal effects.
Conclusions
These findings may provide insights into novel targeted strategies for the management of intestinal disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Inflammation and Translational Gastroenterology (LIGAT), Post-graduation Program in Biotechnology (PPGBIOTEC), Parnaíba Delta Federal University, Av. São Sebastião, 2819, Parnaíba, PI 64202-020, Brazil.
- Post-Graduation Program in Biosciences and Health, Federal University of Rondonópolis, Av. dos Estudantes, 5055 (Faculdade de Ciências da Saúde), Cidade Universitária, Rondonópolis, MT 78736-900, Brazil.
ORCID-Profile: Marcelo Biondaro Gois, Jand Venes Rolim Medeiros
Förderung
- Coordination for the Improvement of Higher Education Personnel
- National Council of Technological and Scientific Development
Zitieren
APA
Lopes, A. L. F., da Silva Araújo, A. K., de Sousa Chaves, L., da Silva Santos, E., de Oliveira, A. C. P., da Silva, K. C., Pacheco, G., Gois, M. B., Nicolau, L. A. D., & Medeiros, J. V. R. (2026). Farnesoid X receptor blockade attenuates morphological damage, intestinal secretion, and prevents mucus loss induced by SARS-CoV-2 spike protein in the mouse intestine. Journal of Pharmacy and Pharmacology, 78(7). https://doi.org/10.1093/jpp/rgag074
Vancouver
Lopes ALF, da Silva Araújo AK, de Sousa Chaves L, da Silva Santos E, de Oliveira ACP, da Silva KC, et al. Farnesoid X receptor blockade attenuates morphological damage, intestinal secretion, and prevents mucus loss induced by SARS-CoV-2 spike protein in the mouse intestine. Journal of Pharmacy and Pharmacology. 2026;78(7). doi:10.1093/jpp/rgag074
BibTeX
@article{Lopes2026,
author = {Lopes, André Luis Fernandes and da Silva Araújo, Andreza Ketly and de Sousa Chaves, Letícia and da Silva Santos, Esley and de Oliveira, Antonio Carlos Pereira and da Silva, Katriane Carvalho and Pacheco, Gabriella and Gois, Marcelo Biondaro and Nicolau, Lucas Antonio Duarte and Medeiros, Jand Venes Rolim},
title = {Farnesoid X receptor blockade attenuates morphological damage, intestinal secretion, and prevents mucus loss induced by SARS-CoV-2 spike protein in the mouse intestine},
journal = {Journal of Pharmacy and Pharmacology},
year = {2026},
volume = {78},
number = {7},
doi = {10.1093/jpp/rgag074}
}
EUVIMED